Heparin for the Treatment of Burn Wound Pain
Information source: King Edward Medical University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Second Degree Burns
Intervention: Polyfax & Lignocain gel or silvazine cream (Drug); Topical Heparin (Drug); Tramadol (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: King Edward Medical University Official(s) and/or principal investigator(s): Muhammad M Bashir, Principal Investigator, Affiliation: King Edward Medical University
Overall contact: Muhammad M Bashir, F.C.P.S, Phone: 923336517745, Email: mmbashir1@gmail.com
Summary
Pain Associated with partial thickness burns (PTB) is very severe and distressing for the
patients. Topical conventional treatment of superficial PTB wounds includes application of
polyfax skin ointment plus lignocain gel twice a day after wound wash while deep PTB are
treated with silvazine cream twice a day and prepared for grafting if not healed within 3
weeks. Existing conventional therapy is un-comfortable and expensive for the patients.
Search continues for a reliable, safe, cheap and effective treatment of burn. Topical use of
heparin has been found effective in reducing pain associated with burn wounds. More over use
of heparin topically in burn patients is easy to perform and cheap but at the moment,
evidence of its effectiveness is weak. Current study is being conducted to verify clinical
effectiveness of use of heparin in 2nd degree burns by comparing it with topical
conventional treatment.
Clinical Details
Official title: Comparative Study of Conventional and Topical Heparin Treatments in Second Degree Burn Patients for Burn Analgesia and Duration of Wound Healing
Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Total consumption of Analgesic MedicationDuration of wound healing Duration of wound healing
Detailed description:
Second degree or partial thickness burn (PTB) is most tricky variety to identify and treat,
out of all four categories of burn (based on depth). It is further divided into superficial
and deep partial thickness based on the depth of dermal injury. (1) Clinical criteria
fulfilling all the points for each category i. e. Superficial PTB (SPTB) being reddish pink,
bleed briskly (in <3sec) on pin prick, blanch with brisk return (in <2 sec) on pressure,
blister formation and Deep PTB (DPTB) being mottled pink, delayed bleeding (in >3 sec) on
pin prick, slow return (in >2 sec) on pressure, no blister, is most commonly used to
differentiate both the sub-classes. Pain is hallmark of 2nd degree burns and is treated by
topical and IV analgesics. Topical conventional treatment of superficial PTB wounds includes
application of polyfax skin ointment plus lignocain gel twice a day after wound wash while
deep PTB are treated with silvazine cream twice a day and prepared for grafting by normal
saline dressings, if not healed within 3 weeks.
Current treatment for 2nd degree burn is complex, uncomfortable for the patient and
expensive for the health systems (2,3) . Search continues for a reliable, safe, cheap and
effective treatment of burn. Heparin has been used topically in burn patient and a
protocol of topical heparin use has been introduced . It is believed that heparin helps in
reducing pain associated with burns and duration of wound healing. (4) It is noted that the
mechanism involved in heparin's action on the burn probably derives from its
anti-inflammatory and angiogenic properties, stimulating tissue repair and
re-epithelializing effects.(2) These actions do not depend on its well-known anticoagulant
action. Burn analgesia by heparin is caused by inhibition of pro-inflammatory products which
act on free nerve endings and cause pain. In this regard, isolated case reports continue to
emerge, suggesting that heparin is able to promote tissue repair and inhibit inflammation in
burn patients.(5) It has been shown in a study that out of total 58 patients, those in
topical Heparin group demanded less analgesic medications in mg/day (11. 83 ± 9. 38) than
Control group (33. 35± 20. 63) . It has been reported in another study that heparin applied
topically for 5 days in 50 pediatric patients reduced healing time. (6) Indeed there are a
number of reports of heparin being used, topically or systemically but there is a lack of
effectively controlled studies in this area for clear conclusions to be drawn as to the
efficacy of this approach.(7) As it is noted that already existing conventional therapy is
un-comfortable and expensive for the patients, use of heparin topically in burn patients is
easy to perform and cheap but at the moment, evidence of its effectiveness is weak. So
rationale of the study is to verify clinical effectiveness of use of heparin in 2nd degree
burns.
Objective:- To compare conventional treatment and topical heparin treatment in 2nd degree
burn patients in terms of total consumption of analgesic medication and duration of wound
healing.
Eligibility
Minimum age: 14 Years.
Maximum age: 60 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
1. Either gender with age limits 14-60 years.
2. 2nd degree burn with Total burn surface area (TBSA) <20% (assessed by Wallace rule of
nine) including front of chest and abdomen, upper limbs excluding hands and lower
limbs excluding foot.
3. Flame and scald burn (on history).
Exclusion Criteria:
1. Third degree (painless, lathery eschar with no blanching) and Fourth degree burns
(full thickness burn with exposed muscle, tendons or bones) as assessed clinically.
2. Chemical or electrical burn (on history).
3. Personal or family history of hemorrhagic diathesis, heparin intolerance, any medical
illness causing bleeding episodes(e. g, Esophageal varices) or active bleeding from
any site.
4. History of Liver disease (Total Bilirubin <20umol/L, Alanine amino transferase
<36u/L, Aspartate amino transferase <42u/L), or renal disorder (Serum
Urea=20-40mg/dl, Serum Creatinine <1. 2).
Locations and Contacts
Muhammad M Bashir, F.C.P.S, Phone: 923336517745, Email: mmbashir1@gmail.com
Department of Plastic Surgery, Mayo Hospital, King Edward Medical University, Lahore, Punjab 54000, Pakistan; Recruiting Muhammad M Bashir, F.C.P.S, Phone: 923336517745, Email: mmbashir1@gmail.com Sobia Manzoor, M.B.B.S, Phone: +923344094072, Email: drsobiamanzoor@yahoo.com
Additional Information
Related publications: Klein MB. Thermal,chemical and electrical injuries In:Thorne CH et al.(ed.)Grabb and Smith's plastic surgery.7th ed. Philadelphia,Lippincott Williams & Wilkins;2014. p128 - 129. ISBN 978-1-4511-0955-9. Barretto MG, Costa Mda G, Serra MC, Afiune JB, Praxedes HE, Pagani E. [Comparative study of conventional and topical heparin treatments for burns analgesia]. Rev Assoc Med Bras. 2010 Jan-Feb;56(1):51-5. Portuguese. Klein MB, Hollingworth W, Rivara FP, Kramer CB, Askay SW, Heimbach DM, Gibran NS. Hospital costs associated with pediatric burn injury. J Burn Care Res. 2008 Jul-Aug;29(4):632-7. doi: 10.1097/BCR.0b013e31817db951. Saliba MJ Jr. Heparin in the treatment of burns 2011". http://www.salibaburnsinstitute.org/ PROTOCOL.html. Ferreira Chacon JM, Mello de Andrea ML, Blanes L, Ferreira LM. Effects of topical application of 10,000 IU heparin on patients with perineal dermatitis and second-degree burns treated in a public pediatric hospital. J Tissue Viability. 2010 Nov;19(4):150-8. doi: 10.1016/j.jtv.2010.03.003. Epub 2010 Apr 20. Venkatachalapathy TS. A comparative study of paediatric thermal burns treated with topical heparin and without heparin. Indian J Surg. 2014 Aug;76(4):282-7. doi: 10.1007/s12262-012-0674-6. Epub 2012 Oct 5. Oremus M, Hanson MD, Whitlock R, Young E, Archer C, Dal Cin A, Gupta A, Raina P. A systematic review of heparin to treat burn injury. J Burn Care Res. 2007 Nov-Dec;28(6):794-804. Review.
Starting date: April 2015
Last updated: July 10, 2015
|